Clinical Outcomes for Patients With Anosmia 1 Year After COVID-19 Diagnosis
Date Added:
June 30, 2021
Journal/Publication:
Journal of the American Medical Association
Publisher:
JAMA Network Open
Issue:
6
Volume:
4
Type:
Clinical Research Results
Format:
Article
DOI (1):
10.1001/jamanetworkopen.2021.15352
PMID (1):
34165581
Abstract
Since the pandemic was declared in early 2020, COVID-19–related anosmia quickly emerged as a telltale sign of infection.1,2 However, the time course and reversibility of COVID-19–related olfactory disorders, which may persist and negatively affect patients’ lives, require further study. To clarify the clinical course and prognosis, we followed a cohort of patients with COVID-19–related anosmia for 1 year and performed repeated olfactory function evaluations for a subset of patients.
Text Availability
Free full text
RPR Commentary
Patients who develop anosmia with COVID-19 almost always recover some or all of their olfactory function over the course of a year. James W. Mold, MD, MPH